Fluvoxamine Maleate

Spécifications

61718-82-9Numéro CAS

612-212-6Numéro CE

(Z)-but-2-enedioic acid;2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamineNom IUPAC

C19H25F3N2O6Formule chimique

434.4 g/molMasse molaire

FLUVOXAMINE MALEATE; 61718-82-9; Luvox; Fevarin; Faverin; Luvox CR; Floxyfral; DU23000; Fluvoxamine hydrogenmaleate; NSC-759602; 5LGN83G74V; DU-23000; DTXSID3042558; Fluoxamine; Faverin 50; Faverin 100; RefChem:56866; Fluvoxamine Maleate, (E)-; DTXCID1022558; DU 23000; 5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one (E)-O-(2-aminoethyl)oxime monomaleate; (E)-Fluvoxamine Maleate; C19H25F3N2O6; MFCD00269809; 54739-20-7; Fluvoxamine (maleate); NSC 309469; (Z)-but-2-enedioic acid;2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine; (E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl) oxime maleate; Fluvoxamine.maleate; (E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone-O-(2-aminoethyl)oxime maleate; 1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime, (E)-, (Z)-2-butenedioate (1:1); Fluvoxamine maleate [USAN]; SMR000466268; SMR000653482; SR-01000075613; SME 3110; MK-264; UNII-5LGN83G74V; Depromel; Fluvoxaminemaleate; Fluvoxamine maleate [USAN:USP]; Luvox (TN); Fluvoxamine maleate CRS; Fluvoxamine maleate, solid; 5-Methoxy-4'-trifluoromethylvalerophenone (E)-O-2-aminoethyloxime monomaleate; 5-Methoxy-4'-(trifluoromethyl)valerophenone (E)-O-(2-aminoethyl)oxime, maleate (1:1); CHEMBL1409; SCHEMBL35225; MLS000028469; MLS000758271; MLS001076285; MLS001304717; MLS001401391; CHEBI:5139; HY-B0103AR; orb1309842; orb3141233; FLUVOXAMINE MALEATE [MI]; HY-B0103A; FLUVOXAMINE MALEATE [JAN]; Fluvoxamine (maleate) (Standard); Fluvoxamine maleate (JP18/USP); GLXC-07697; HMS1571G11; HMS2098G11; HMS3261D11; HMS3412A13; HMS3676A13; HMS3715G11; HMS3884K11; HMS5079B13; Pharmakon1600-01505604; FLUVOXAMINE MALEATE [VANDF]; FLUVOXAMINE MALEATE [MART.]; SME-3110; Tox21_500495; EBC-13000; FLUVOXAMINE MALEATE [USP-RS]; FLUVOXAMINE MALEATE [WHO-DD]; Fluvoxamine Maleate Impurity Standard; HB2138; NSC309469; NSC759602; s1336; AKOS015961142; Fluvoxamine for system suitability CRS; AC-9541; CCG-213494; CS-1839; FF02412; NSC 759602; NSC-309469; Fluvoxamine maleate - Bio-X trade mark; FLUVOXAMINE MALEATE [ORANGE BOOK]; NCGC00093897-01; NCGC00093897-02; NCGC00261180-01; (E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)-1-pentanone O-(2-aminoethyl)oxime (Z)-2-butenedioate (1:1); AS-11790; BF164482; FLUVOXAMINE MALEATE [EP MONOGRAPH]; SMR000058449; SY066847; FLUVOXAMINE MALEATE [USP MONOGRAPH]; EU-0100495; F0858; F4783; T1077; D00824; D70454; F 2802; EN300-1692902; SR-01000075613-1; SR-01000075613-3; SR-01000075613-4; SR-01000075613-6; Q27262521; Fluvoxamine.maleate, 1mg/ml in Methanol (as free base); Z2568647847; Fluvoxamine maleate, British Pharmacopoeia (BP) Reference Standard; Fluvoxamine maleate, European Pharmacopoeia (EP) Reference Standard; Fluvoxamine maleate, United States Pharmacopeia (USP) Reference Standard; (E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone O-(2-Aminoethyl)oxime Maleate; 5-Methoxy-1-(4-trifluoromethyl-phenyl)-pentan-1-one O-(2-amino-ethyl)-oxime maleate; Fluvoxamine for system suitability, European Pharmacopoeia (EP) Reference Standard; Fluvoxamine maleate, 1.0 mg/mL in methanol ((as free base)), certified reference material; Fluvoxamine Maleate, Pharmaceutical Secondary Standard; Certified Reference Material; maleic acid;2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine; (2Z)-But-2-enedioic acid--2-{[(E)-{5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino]oxy}ethan-1-amine (1/1); (2Z)-but-2-enedioic acid; (E)-(2-aminoethoxy)({5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene})amine; 5-METHOXY-4'-(TRIFLUOROMETHYL)VALEROPHENONE-(E)-O-(2-AMINOETHYL)OXIME MALEATE (1:1)Synonymes